June 28, 2017 - By Richard Conner
Cardiome Pharma Corp. is a specialty pharmaceutical company. The company has market cap of $130.64 million. The Firm is engaged in the development and commercialization of cardiovascular therapies for heart disease. It currently has negative earnings. The Company’s divisions are Europe and Rest of World.
Grisanti Capital Management Llc increased Amerigas Partners LP (APU) stake by 103.32% reported in 2016Q4 SEC filing. Grisanti Capital Management Llc acquired 14,206 shares as Amerigas Partners LP (APU)’s stock declined 9.65%. The Grisanti Capital Management Llc holds 27,955 shares with $1.34M value, up from 13,749 last quarter. Amerigas Partners LP now has $4.11B valuation. The stock rose 0.31% or $0.14 reaching $44.65 per share. About 9,495 shares traded. AmeriGas Partners, L.P. (NYSE:APU) has declined 1.59% since June 28, 2016 and is downtrending. It has underperformed by 18.29% the S&P500.
About 700 shares traded. CARDIOME PHARMA CORP (CRME) has declined 11.02% since June 28, 2016 and is downtrending. It has underperformed by 27.72% the S&P500.
Clough Capital Partners L P holds 0.56% of its portfolio in CARDIOME PHARMA CORP for 3.06 million shares. Alphaone Investment Services Llc owns 550,965 shares or 0.42% of their US portfolio. Moreover, Rock Springs Capital Management Lp has 0.22% invested in the company for 1.20 million shares. The Massachusetts-based Westfield Capital Management Co Lp has invested 0.12% in the stock. Sabby Management Llc, a New Jersey-based fund reported 437,720 shares.
Among 6 analysts covering AmeriGas Partners LP (NYSE:APU), 2 have Buy rating, 3 Sell and 1 Hold. Therefore 33% are positive. AmeriGas Partners LP had 9 analyst reports since August 20, 2015 according to SRatingsIntel. Barclays Capital maintained AmeriGas Partners, L.P. (NYSE:APU) on Thursday, August 4 with “Underweight” rating. JP Morgan maintained the stock with “Neutral” rating in Monday, November 2 report. The rating was downgraded by UBS on Friday, June 10 to “Sell”. Janney Capital reinitiated the stock with “Buy” rating in Thursday, May 26 report. The company was maintained on Thursday, November 19 by UBS. The stock of AmeriGas Partners, L.P. (NYSE:APU) has “Buy” rating given on Saturday, August 29 by TheStreet. The rating was downgraded by Bank of America to “Underperform” on Friday, February 3.
Grisanti Capital Management Llc decreased Allergan Plc stake by 21,845 shares to 30,357 valued at $6.38 million in 2016Q4. It also reduced Chubb Ltd stake by 3,881 shares and now owns 79,309 shares. Chevron Corp New (NYSE:CVX) was reduced too.
Since February 6, 2017, it had 0 insider purchases, and 1 sale for $515,452 activity. Sheridan Jerry E had sold 10,590 shares worth $515,452 on Monday, February 6.
Investors sentiment decreased to 1.03 in Q4 2016. Its down 0.40, from 1.43 in 2016Q3. It fall, as 23 investors sold APU shares while 54 reduced holdings. 30 funds opened positions while 49 raised stakes. 21.43 million shares or 1.17% more from 21.19 million shares in 2016Q3 were reported. Camarda Financial Advsrs Ltd holds 0.32% or 9,719 shares. Susquehanna International Group Ltd Liability Partnership holds 15,700 shares or 0% of its portfolio. Northstar Llc holds 0.13% or 12,265 shares in its portfolio. Cetera Advisors Lc invested 0.05% of its portfolio in AmeriGas Partners, L.P. (NYSE:APU). First Interstate Bancorp holds 0.03% or 3,350 shares. Duff Phelps Invest Mngmt reported 0.05% in AmeriGas Partners, L.P. (NYSE:APU). Kanaly Trust reported 100 shares. Bokf Na reported 0.01% of its portfolio in AmeriGas Partners, L.P. (NYSE:APU). Karpas Strategies Limited Liability Corporation accumulated 4,400 shares. Delta Asset Mgmt Lc Tn stated it has 300 shares. Cumberland Advsr reported 0.01% stake. Blume Mngmt invested 0.01% in AmeriGas Partners, L.P. (NYSE:APU). Sterling Mngmt Lc invested 0% in AmeriGas Partners, L.P. (NYSE:APU). Maryland-based Edgemoor Investment Advsr has invested 1.08% in AmeriGas Partners, L.P. (NYSE:APU). Bessemer Group invested in 0.04% or 186,972 shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.